18F‐fluorodeoxyglucose positron emission tomography imaging in brain tumours: The Western Australia positron emission tomography/cyclotron service experience
- 1 December 2008
- journal article
- Published by Wiley in Journal of Medical Imaging and Radiation Oncology
- Vol. 52 (6) , 564-569
Abstract
18F‐fluorodeoxyglucose positron emission tomography (FDG‐PET) scans in the first 49 patients referred with either possible brain tumour or brain tumour recurrence were reviewed. FDG‐PET imaging was reported with reference to anatomical imaging. Based on the report the FDG study was classified as either positive or negative for the presence of tumour. Thirty‐eight cases were included in the analysis, 21 having pathological data and 17 with diagnostic clinical follow up. Eleven were excluded, as they had inadequate follow‐up data. Of the 21 cases with pathology, 18 were shown to have tumour. In this group there were five false‐negative scans and two false‐positive PET scans. Seventeen cases were assessed by clinical follow up, nine were considered to have been tumour. There were two false negatives with one false positive. The overall sensitivity, specificity and positive and negative predictive values were 74, 73, 87 and 53% respectively. This is similar to figures previously quoted in published work. Despite relatively limited numbers, the utility of FDG PET imaging in our hands is similar to published reports. With a positive predictive value of 87%, a positive FDG study indicates a high likelihood that there is brain tumour present. A negative study does not exclude the presence of tumour.Keywords
This publication has 12 references indexed in Scilit:
- Positron emission tomography in clinical neurologyMolecular Imaging and Biology, 2004
- Imaging gliomas with positron emission tomography and single-photon emission computed tomographySeminars in Nuclear Medicine, 2003
- Positron emission tomography imaging of brain tumorsNeuroimaging Clinics Of North America, 2002
- Predictive value of clinical evaluation in the follow-up of children with a brain tumor.Medical and Pediatric Oncology, 2002
- Can the standardized uptake value characterize primary brain tumors on FDG-PET?European Journal of Nuclear Medicine and Molecular Imaging, 1999
- Pitfalls in Oncologic Diagnosis with FDG PET Imaging: Physiologic and Benign VariantsRadioGraphics, 1999
- Central nervous system imagingPostgraduate Medicine, 1998
- PET and [18F]-FDG in oncology: A clinical updateNuclear Medicine and Biology, 1996
- PET FDG studies in oncologyNuclear Medicine and Biology, 1994
- Differentiation of residual or recurrent tumors from post-treatment changes with F-18 FDG PET.RadioGraphics, 1992